torcetrapib has been researched along with Flushing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for torcetrapib and Flushing
| Article | Year |
|---|---|
Niacin into the void. Failure of HDL cholesterol drug may B this vitamin's big chance.
Topics: Cholesterol, HDL; Flushing; Humans; Hypolipidemic Agents; Niacin; Quinolines; Treatment Failure | 2007 |